Keywords: CEST / APT / NOE, Brain
Motivation: Precise glioma classification is essential for personalized treatment, but non-invasive tools struggle with molecular differentiation. APT imaging shows promise, yet multicenter validation is lacking.
Goal(s): This prospective study evaluates APT imaging’s ability to classify adult-type diffuse gliomas by grade, subtype, and IDH status across multiple centers.
Approach: Using standardized MRI protocols, 123 patients from three centers were analyzed. APT metrics were assessed for consistency and diagnostic performance.
Results: APT imaging reliably distinguished glioma grades and IDH mutations across centers, though some challenges remain in differentiating certain subtypes.
Impact: This study demonstrates that APT imaging reliably differentiates adult-type gliomas across centers, enabling more precise, non-invasive tumor characterization. It promotes earlier, molecularly informed diagnoses, guiding personalized treatment strategies and fostering research on APT imaging's prognostic and therapeutic potential.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords